2026. Machine Learning-Driven Comparative Effectiveness Research: Utilizing Random Forest and XGBoost to Predict Patient Response and Adverse Drug Reactions to First-Line Antidiabetic Therapies. The Science Post. 2, 2 (Jun. 2026).